On July 1, 2023, Sunovion Pharmaceuticals Inc. became part of Sumitomo Pharma America, Inc., a biopharmaceutical company focused on delivering therapeutic...
8 KB (684 words) - 22:18, 3 June 2024
Sepracor for $2.6B in 2010, renaming its new stand-alone subsidiary Sunovion. Under Sunovion management, Sumitomo Dainippon Pharma was able to successfully...
10 KB (777 words) - 04:16, 10 June 2024
medication was discovered in collaboration between PsychoGenics Inc. and Sunovion Pharmaceuticals (which was subsequently merged into Sumitomo Pharma) using...
10 KB (815 words) - 14:07, 11 January 2024
reuptake inhibitor (SNDRI) that was under development by Sunovion for the treatment of attention-deficit hyperactivity disorder (ADHD) and...
8 KB (638 words) - 18:19, 15 January 2024
its U.S. commercial rights for Seebri Neohaler and Utibron Neohaler to Sunovion Pharmaceuticals. "Product monograph brand safety updates". Health Canada...
4 KB (210 words) - 04:40, 3 April 2024
1847– ) Strides (1990– ) Stryker (1941– ) Sumitomo (2005– ) Sun (1983– ) Sunovion (formerly Sepracor) (1984– ) Sutro (2003– ) Swedish Orphan Biovitrum (2001–...
34 KB (2,168 words) - 15:30, 26 August 2024
Wyeth Lurasidone Benzisothiazole Atypical Latuda 2010 Sumitomo Dainippon/Sunovion Melperone Butyrophenone Disputed Buronil 1967 Lundbeck Mesoridazine...
208 KB (18,301 words) - 13:54, 4 September 2024
Novartis licensed its U.S. commercial rights for Arcapta Neohaler to Sunovion Pharmaceuticals. "Arcapta Neohaler (indacaterol) inhalation powder Initial...
7 KB (411 words) - 20:05, 20 December 2023
Liming Shao, et al. WO2007081542 (Sunovion Pharmaceuticals Inc). Liming Shao & Jianguo Ma, WO2010091268 (Sunovion Pharmaceuticals Inc). Heike Radeke...
128 KB (15,244 words) - 05:38, 25 July 2024
PMID 35047111. "Sunovion: creating therapies to help transform people's lives". www.sunovion.com. Retrieved 4 June 2022. "Sunovion and PsychoGenics Announce...
32 KB (2,036 words) - 11:13, 25 February 2024